Ackermans & van Haaren supports MRM Health’s Series B financing round of 55 million euros

About this update from Ackermans & Van Haaren Nv

Dear shareholder, Dear Madam, Dear Sir, Ackermans & van Haaren (AvH) supports the Series B financing round totaling 55 million euros of MRM Health, a clinical-stage biopharmaceutical company pioneering microbiome-based therapeutics for inflammatory diseases and immune-oncology. For AvH, this series B financing round involves an additional investment of 3 million euros and brings its total investment in MRM Health to 10.8 million euros and its fully diluted participation to 14.1%. Please find the full press release in annex. Best regards Ackermans & van Haaren Attachment Ackermans & van Haaren supports MRM Health’s Series B financing round (20250904)

View stock analysis, news, and events for Ackermans & Van Haaren Nv